|
1.
Share Success: Letters From Readers
Letter
I: From Karen D.
Received
at CustomerService @ ezorbonline.com 12/27/17 at 1:38 PM
(Unedited)
I love taking the Calcium Aspartate Anhydrous and have used it for quite a few years.
Years ago a doctor diagnosed me with osteoporosis and put me on medication. After being on osteoporosis medication for quite some time, I started having problems with my jaw. I later found that this medication I was on would create this problem after being on it for a while.
My dentist was having patients that were also having problems with this medication. I don't know what the other patients did about this medication, but, I went online to find something that would help me.
I came across EZorb and decided to try it. I have never regretted making this change. It took some time, but I was able to get rid of my jaw locking up and get rid of the pain in my joints. I quit buying arthritis medication or pills.
Also my husband takes the powder form of EZorb and has never any arthritis or joint pain.
Letter
II: From Marty
Received
at Testimonial
Submit Form Monday, October 30, 2017 at 22:49:20
(Unedited)
Hi, my name is Marty.
I used to enjoy hiking in Wyoming and Texas but a growing bone spur would cause me to limp for 2-3 days afterwards.
VA prescribed Meloxicam and padded insoles for my shoes. They helped only very mildly. I would pump myself up with anti-inflammatory before hiking to no avail.
I read these stories about EZorb so I bought 2 bottles and took 10 pills a day till they were gone. I finished them 3 days after leaving with my wife on a 7 week swing from Tampa to Mn. to Spokane and south through 17 National Parks and Monuments.
I have been pain free on my left heel, ankle and foot; hiking in every Park I could with great success! Don't know how worked nor why, but veryyyy thankful to this company for this Organic natural cure.
***************************************************
From
the Desk of EZorb Newsletter Editor:
This
newsletter is now read by over 95,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public. If your testimonial is selected for publication, you will receive a gift to show
our appreciation of your effort.
2.
Research News: Ibuprofen May Elevate Blood Pressure
Patients with osteoarthritis (OA) or rheumatoid arthritis (RA) who take ibuprofen are more likely to experience an increase in systolic blood pressure (SBP) than those taking celecoxib, results of the PRECISION-ABPM study suggest.
Given "the established continuous relationship between BP and both cardiovascular and cerebrovascular events," these findings "could impact clinical outcomes for patients chronically using NSAIDs [non-steroidal anti-inflammatory drugs]," say Frank Ruschitzka (University Hospital Zurich, Switzerland) and fellow researchers.
The study results were presented at the European Society of Cardiology conference in Barcelona, Spain, and published simultaneously in the European Heart Journal.
Ruschitzka and team compared BP changes among 444 patients who already had or were at risk for coronary artery disease and were randomly assigned to receive the NSAIDs ibuprofen or naproxen versus the selective cyclooxygenase (COX)-2 inhibitor celecoxib in the PRECISION trial. The majority (92%) of patients had a diagnosis of OA, and the remaining 8% had RA.
The 151 participants receiving ibuprofen who completed the PRECISION-ABPM substudy experienced an increase in average 24-hour ambulatory SBP from 125.24 mmHg at baseline to 128.65 mmHg at month 4, whereas the 147 in the naproxen group experienced a smaller increase from 123.55 mmHg to 125.46 mmHg. By contrast, the 146 patients receiving celecoxib experienced a decrease in mean SBP from 124.18 mmHg at baseline to 124.00 mmHg at month 4.
These results translated into a significant 3.9 mmHg difference among participants receiving ibuprofen versus those receiving celecoxib, and nonsignificant differences for patients receiving ibuprofen versus naproxen and celecoxib versus naproxen.
Moreover, average 24-hour mean arterial BP at month 4 was increased among participants receiving ibuprofen, but not among those in the celecoxib or naproxen groups. And a significantly higher proportion of patients in the ibuprofen and naproxen groups who did not have elevated BP at baseline developed hypertension over the study period compared with those in the celecoxib group.
Of note, pain control was comparable for participants in the three groups, with average reductions in visual analog scale for pain scores from baseline of 9.4, 12.4, and 7.9 points over the study period for patients in the ibuprofen, celecoxib, and naproxen groups, respectively.
"The findings of PRECISION-ABPM concur with the primary outcome results of the overall PRECISION trial that showed that ibuprofen-treated patients, compared with those who received naproxen and celecoxib, experienced numerically more cardiovascular and renal events," write the researchers.
"Given the widespread use of NSAIDs, even a small rise in SBP among hypertensive patients with osteoarthritis could substantially increase cardiovascular events in a population," they add.
Ruschitzka told the press that the team's findings challenge "the widely advocated belief that conventional NSAIDs, like naproxen and ibuprofen, with their higher COX-1 (and thromboxane reducing) effects would provide greater cardiovascular safety than other more COX-2 selective agents, particularly celecoxib."
And he added: "Patients should continue to consult their doctor before taking NSAIDs or [COX-2 inhibitors] and clinicians need to weigh the potential hazards of worsening blood pressure control when considering the use of these agents."
Original article appeared in 08-30-2017 | Rheumatology | News | Article.
3.
Useful Links
Frequently
Asked Questions & Answers
EZorb
Clinical Studies
Marvlix
Benefits
Order
Now
4.
Calcium
Absorption Test
EZorb
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
5.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix. |
